NCT00136903 2022-01-31
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)
Mesoblast, Ltd.
Phase 2 Completed
Mesoblast, Ltd.
Nohla Therapeutics, Inc.
Regimmune Corporation
Nohla Therapeutics, Inc.